Features of the Current Epidemic Process of Infectious Mononucleosis in the Nizhny Novgorod Region
https://doi.org/10.35627/2219-5238/2021-337-4-79-86
Abstract
Introduction: Today, we are witnessing the process of forming a fundamentally new epidemiological situation on infectious mononucleosis. Over the past decade, a general increase in the incidence of infectious mononucleosis, its proportion in the structure of respiratory tract infections, and economic importance was noted in Russia. Information about the epidemic process of infectious mononucleosis in different areas is limited. Our objective was to study the features of the epidemic process of infectious mononucleosis in the Nizhny Novgorod Region in 2010–2019. Methods: We conducted a retrospective epidemiological analysis of the incidence of infectious mononucleosis in the Nizhny Novgorod Region for 2010–2019 based on official statistics using standard statistical approaches. Results and discussion: The long-term incidence rate of infectious mononucleosis in the Nizhny Novgorod Region was stable (+0.6 %) with the long-term average rate of 12.6 ± 0.6 ‰оо. An autumn-winter-spring seasonality with two distinct peaks (in November–December and May) was revealed. The majority of cases were children aged 0–14 years (72.8 ± 2.2 %). The highest incidence rates were registered in the age groups of 1–2 and 3-6 years. We established a reverse trend in the disease incidence among children aged 0–6 (decrease) and 7 years and older (increase). Adolescents aged 15–17 demonstrated the most pronounced growth rate (+7.5 %). The typical annual dynamics in adults was distinguished by a clear spring-summer seasonality, the absence of a characteristic growth in the autumn months, and a low rate in December. The identified features of the epidemic process in different age groups require clarification and detailing. Conclusions: We established recent patterns and features of the epidemic process of infectious mononucleosis in the Nizhny Novgorod Region. This work is an important component of epidemiological surveillance of infection and a scientific basis for improving the existing system of preventive and anti-epidemic measures.
About the Authors
M. I. PopkovaRussian Federation
Mariia I. Popkova, Candidate of Medical Sciences, Leading Researcher, Laboratory of Molecular Biology and Biotechnology
71 Malaya Yamskaya Street, Nizhny Novgorod, 603950
O. V. Utkin
Russian Federation
Oleg V. Utkin, Candidate of Biological Sciences, Leading Researcher, Head of the Laboratory of Molecular Biology and Biotechnology
71 Malaya Yamskaya Street, Nizhny Novgorod, 603950
References
1. Sprunt TP, Evans FA. Mononuclear leukocytosis in reaction to acute infections (“infectious mononucleosis”). Bulletin of the Johns Hopkins Hospital. 1920;(31):410–7.
2. Takeuchi K, Tanaka-Taya K, Kazuyama Y, Ito YM, Hashimoto S, Fukayama M, et al. Prevalence of Epstein- Barr virus in Japan: trends and future prediction. Pathol Int. 2006;56(3):112–6. doi: 10.1111/j.1440-1827.2006.01936.x
3. Dowd JB, Palermo T, Brite J, McDade TW, Aiello A. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6–19, 2003–2010. PLoS One. 2013;8(5):e64921. doi: 10.1371/journal.pone.0064921
4. Fourcade G, Germi R, Guerber F, Lupo J, Baccard M, Seigneurin A, et al. Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016. PLoS One. 2017;12(4):e0175574. doi: 10.1371/journal.pone.0175574
5. Morris MC, Edmunds WJ. The changing epidemiology of infectious mononucleosis? J Infect. 2002;45(2):107-9, doi: 10.1053/jinf.2002.1022
6. Devkota K, He M, Liu MY, Li Y, Zhang YW. Increasing Epstein-Barr virus infection in Chinese children: A single institutional based retrospective study. F1000Res. 2018;7:1211. doi: 10.12688/f1000research.15544.2
7. Mazur-Melewska K, Breńska I, Jończyk-Potoczna K, Kemnitz P, Pieczonka-Ruszkowska I, Mania A, et al. Neurologic complications caused by Epstein-Barr virus in pediatric patients. J Child Neurol. 2016;31(6):700–8. doi: 10.1177/0883073815613563
8. Rostgaard K, Balfour Jr HH, Jarrett R, Erikstrup C, Pedersen O, Ullum H, et al. Primary Epstein-Barr virus infection with and without infectious mononucleosis. PLoS One. 2019;14(12):e0226436. doi: 10.1371/journal.pone.0226436
9. Mikhneva SA, Martinov YuV, Kukhtevich EV, Grishina YuYu. Infectious mononucleosis: a spatiotemporal manifestation of the epidemic process. Zdorov’e Naseleniya i Sreda Obitaniya. 2018;(10(307)):50–54. (In Russian). doi: 10.35627/2219-5238/2018-307-10-50-54
10. Solomay TV. Dynamics of morbidity and territorial spread of infectious mononucleosis. Zdravookhranenie Rossiiskoy Federatsii. 2019;63(4):186–192. (In Russian). doi: 10.18821/0044-197Х-2019-63-4-186-92
11. Timchenko VN, Bannova SL, Pavlova NV, Pavlova EB, Kaplina TA, Fedorova A.V, et al. VEB-mononucleosis in children at the hospital stage in modern conditions. Pediatr. 2018;9(6):77–82. (In Russian). doi: 10.17816/ PED9677-82
12. Hakizimana JK, Timchenko VN, Shakmaeva MA, Kaplina TA, Subbotina MD, Bannova SL, et al. EBV mononucleosis in children in modern conditions. Detskie Infektsii. 2020;19(2(71)):23–28. (In Russian). doi: 10.22627/2072-8107-2020-19-2-23-28
13. Demina OI, Chebotareva TA, Mazankova LN, Tetova VB, Uchaeva ON. Clinical manifestations of infectious mononucleosis in primary or reactivated herpes virus infection. Rossiyskiy Vestnik Perinatologii i Pediatrii. 2020;65(1):37–44. (In Russian). doi: 10.21508/1027-4065-2020-65-1-37-44
14. Khmilevskaya SA, Zaytseva IA. Clinical and epidemiologic aspects of infectious mononucleosis in children. Epidemiologiya i Vaktsinoprofilaktika. 2010;(5(54)):45–50. (In Russian).
15. Potekhina NN, Kovalishena OV, Piskarev YG, Nikiforov VA, Ershov VI.; Shkarin VV, Rakhmanov RS, eds. Fundamentals of a Retrospective Analysis of Infectious Morbidity: a Textbook. Nizhny Novgorod: Nizhegorodskaya Gosudarstvennaya Meditsinskaya Akademiya, Publ.; 2009. (In Russian).
16. Visser E, Milne D, Collacott I, McLernon D, Counsell C, Vickers M. The epidemiology of infectious mononucleosis in Northern Scotland: a decreasing incidence and winter peak. BMC Infect Dis. 2014;14:151. doi: 10.1186/1471-2334-14-151
17. Trunova OA, Romanenko TA, Staren’kova OV, Susidko VV. Some aspects of the epidemic process of Epstein-Barr viral infection. Universitetskaya Klinika. 2017;(3-1(24)):204–9. (In Russian).
18. Solomay TV, Filatov NN. Seasonality of infection caused by Epstein – Barr virus. Zhurnal Infektologii. 2020;12(4):93–100. (In Russian). doi: 10.22625/2072-6732-2020-12-4-93-100
Review
For citations:
Popkova M.I., Utkin O.V. Features of the Current Epidemic Process of Infectious Mononucleosis in the Nizhny Novgorod Region. Public Health and Life Environment – PH&LE. 2021;(4):79-86. (In Russ.) https://doi.org/10.35627/2219-5238/2021-337-4-79-86